Golden Ally Lifetech Group, Inc. AQPW
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 216.81% | 8,674.12% | 12,048.91% | 4,246.62% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 207.62% | 2,891.65% | 2,760.59% | 2,783.45% | -- |
| Operating Income | -207.62% | -2,891.65% | -2,760.59% | -2,783.45% | -- |
| Income Before Tax | -221.16% | -8,801.76% | -12,065.38% | -4,254.83% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -221.16% | -8,801.76% | -12,065.38% | -4,254.83% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -207.67% | -2,892.19% | -2,761.22% | -2,784.31% | -- |
| EBIT | -207.62% | -2,891.65% | -2,760.59% | -2,783.45% | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 84.00% | 90.14% | 93.10% | 29.85% | -- |
| Normalized Basic EPS | 0.00% | 0.00% | 76.92% | 92.59% | -- |
| EPS Diluted | 84.00% | 90.14% | 93.10% | 29.85% | -- |
| Normalized Diluted EPS | 0.00% | 0.00% | 76.92% | 92.59% | -- |
| Average Basic Shares Outstanding | -11.19% | 11.56% | 89,294.03% | 79,711.53% | -- |
| Average Diluted Shares Outstanding | -11.19% | 11.56% | 89,294.03% | 79,711.53% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |